Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    entities : Ac immune sa    save search

AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.34% C: -0.85%
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 10.68% H: 0.0% C: -7.34%

aci-24 vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta phase 2b
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development
Published: 2022-11-30 (Crawled : 12:20) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.93% C: 0.92%
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 9.16% H: 0.0% C: -10.84%

aci-35 disease aci-35.030 alzheimer’s vaccine
AC Immune’s Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology
Published: 2022-05-09 (Crawled : 15:20) - globenewswire.com
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 0.0% C: -12.05%

vaccine results aci-24 phase 2b
AC Immune ACI-35.030 Phase 1b/2a Trial Interim Data Confirm Consistent Safety and Potent Immunogenicity of pTau Alzheimer’s Vaccine in High-dose Cohort
Published: 2022-02-15 (Crawled : 14:30) - globenewswire.com
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 2.07% H: 3.61% C: 1.58%

aci-35 alzheimer phase 1b trial phase 1 aci-35.030 vaccine alzheimer’s alzheimer's phase 2b
AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinson’s Disease at AAIC 2021
Published: 2021-07-29 (Crawled : 12:00) - globenewswire.com
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 2.04% H: 1.06% C: -5.45%

disease phase 1 results parkinson vaccine phase 1b diagnostic phase 2b
AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
Published: 2021-07-27 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.14% C: -0.05%
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 1.83% H: 2.76% C: -1.24%

disease acquisition parkinson vaccine aci-7104
AC Immune Provides Update on Alzheimer’s Disease Vaccine Candidates Targeting Pathological Amyloid-Beta
Published: 2021-06-02 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.96% C: 0.06%
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 9.89% H: 2.4% C: -9.71%

disease alzheimer vaccine aci-24 alzheimer’s alzheimer's disease alzheimer's
AC Immune to Highlight Promising Alzheimer’s Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference
Published: 2021-02-17 (Crawled : 13:00) - globenewswire.com
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 3.57% H: 15.2% C: 9.23%

alzheimer vaccine alzheimer’s alzheimer's
New Vaccine Formulation Shows Promise for Alzheimer's Target
Published: 2021-02-11 (Crawled : 16:00) - biospace.com/
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 58.96% H: 7.57% C: -27.45%

alzheimer new vaccine vaccine alzheimer’s alzheimer's
AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study
Published: 2021-02-11 (Crawled : 13:00) - globenewswire.com
ACIU | $2.375 -0.21% -0.21% 320K twitter stocktwits trandingview |
Health Technology
| | O: 58.96% H: 7.57% C: -27.45%

alzheimer phase 1 antibody vaccine phase 1b phase 2b response alzheimer’s alzheimer's
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.